17 July, 2025One Biosciences announces €15 Million Series A financing to advance clinical single cell profiling
14 July, 2025Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension
9 July, 2025Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)